The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Ferguson, Michael Anthony John, Professor Sir
    Director born in February 1957
    Individual (4 offsprings)
    Officer
    2023-09-25 ~ now
    OF - director → CIF 0
  • 2
    Wolf, Charles Roland, Professor
    University Research Professor born in February 1949
    Individual (3 offsprings)
    Officer
    2022-10-21 ~ now
    OF - director → CIF 0
    Professor Charles Roland Wolf
    Born in February 1949
    Individual (3 offsprings)
    Person with significant control
    2022-10-21 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
  • 3
    Wolfe, Richard
    Director born in October 1946
    Individual (1 offspring)
    Officer
    2023-09-25 ~ now
    OF - director → CIF 0
Ceased 1
  • Rounding, Howard Paul
    Director born in April 1960
    Individual (3 offsprings)
    Officer
    2023-09-25 ~ 2024-02-07
    OF - director → CIF 0
parent relation
Company in focus

PHASER BIOMEDICAL LTD

Standard Industrial Classification
62090 - Other Information Technology Service Activities
63120 - Web Portals
71200 - Technical Testing And Analysis
72110 - Research And Experimental Development On Biotechnology
Brief company account
Total Inventories
8,277 GBP2023-12-31
Cash at bank and in hand
983,297 GBP2023-12-31
Net Assets/Liabilities
250,649 GBP2023-12-31
Equity
Called up share capital
1 GBP2023-12-31
Share premium
266,999 GBP2023-12-31
Retained earnings (accumulated losses)
-16,351 GBP2023-12-31
Equity
250,649 GBP2023-12-31
Average Number of Employees
32022-10-21 ~ 2023-12-31
Trade Creditors/Trade Payables
Current
28,227 GBP2023-12-31
Other Creditors
Current
719,082 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
11,092 shares2023-12-31
Par Value of Share
Class 1 ordinary share
0.0001 GBP2022-10-21 ~ 2023-12-31
Nominal value of allotted share capital
Class 1 ordinary share
1 GBP2022-10-21 ~ 2023-12-31

  • PHASER BIOMEDICAL LTD
    Info
    Registered number SC748032
    Burges Salmon Llp Atria One, 144 Morrison Street, Edinburgh EH3 8EX
    Private Limited Company incorporated on 2022-10-21 (2 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-20
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.